Innovative Strategies and Efforts of Clinical Pharmacy Services During and After COVID-19 Epidemic: Experience from Shanghai Children’s Hospital

Coronavirus disease 2019 (COVID-19), the result of infection by the SARS-CoV-2 virus, has caused a global pandemic. To respond to this outbreak rapidly and properly, clinical pharmacists in Shanghai Children’s Hospital carried out innovative measures based on previous artificial intelligence experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiling, Gan, Li, Zheng, Huan, Ni, Yujia, Sun, Huajun, Yang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630467/
https://www.ncbi.nlm.nih.gov/pubmed/34858072
http://dx.doi.org/10.2147/RMHP.S324937
Descripción
Sumario:Coronavirus disease 2019 (COVID-19), the result of infection by the SARS-CoV-2 virus, has caused a global pandemic. To respond to this outbreak rapidly and properly, clinical pharmacists in Shanghai Children’s Hospital carried out innovative measures based on previous artificial intelligence experiences, such as using service robots for contactless drug delivery between Fever Clinic and Pharmacy Storage, providing telemedicine counseling on specific platforms and offering multimedia health education. With good control of the pandemic in Shanghai, these contactless services have been retained and expanded at the patients’ request. The aim of this article is to share our strategies and efforts with peers who are fighting against COVID-19 in other countries and regions.

Ejemplares similares